Page last updated: 2024-11-04

terazosin and Chronic Kidney Failure

terazosin has been researched along with Chronic Kidney Failure in 2 studies

Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia

Research Excerpts

ExcerptRelevanceReference
"Terazosin is a new, long-acting, selective, postsynaptic alpha 1-adrenergic receptor antagonist with a chemical structure similar to that of prazosin."2.38Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events. ( Achari, R; Laddu, AR; Somberg, JC, 1991)
" The plasma half-life of terazosin in patients with normal renal function was 10."1.27Influence of renal insufficiency on the pharmacokinetics and pharmacodynamics of terazosin. ( Chauveau, P; Ganeval, D; Jungers, P; Pertuiset, N, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Somberg, JC1
Achari, R1
Laddu, AR1
Jungers, P1
Ganeval, D1
Pertuiset, N1
Chauveau, P1

Reviews

1 review available for terazosin and Chronic Kidney Failure

ArticleYear
Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events.
    American heart journal, 1991, Volume: 122, Issue:3 Pt 2

    Topics: Adrenergic alpha-Antagonists; Age Factors; Antihypertensive Agents; Dose-Response Relationship, Drug

1991

Other Studies

1 other study available for terazosin and Chronic Kidney Failure

ArticleYear
Influence of renal insufficiency on the pharmacokinetics and pharmacodynamics of terazosin.
    The American journal of medicine, 1986, May-23, Volume: 80, Issue:5B

    Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Female; Half-Life; Humans; Kidney Failure, Chro

1986